Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when ARS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get SPRY alerts

About Meg Smith

Meg Smith has spoken on 1 earnings call across 1 company, most recently for ARS Pharmaceuticals, Inc. on November 5, 2026. ARS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at ARS Pharmaceuticals, Inc. includes Donn Casale (CEO and Board Member), Rich Lowenthal (CEO), Richard Lowenthal (CEO) and 7 others.

Meg Smith on recent calls

“What I've seen in my first two months confirms that NEPHE is a meaningful advance in a market where patients need a better solution. NEPHE competes in an existing market of more than 5 million U.S. prescriptions annually, almost all of which are needle-based auto-injectors.”
Other, ARS Pharmaceuticals, Inc. Q3 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at ARS Pharmaceuticals, Inc.

Recent activity